The U.S. Food and Drug Administration's decision to temporarily halt the use of the Johnson & Johnson COVID-19 vaccine is having ramifications globally.
Many federally recognized tribes throughout the U.S. have had great success vaccinating their members against COVID-19. But those without federal recognition say they have a very different story.
Which communities could suffer most from the Johnson & Johnson vaccination pause? NPR's Ailsa Chang talks to Dr. Paul Adamson, an infectious diseases fellow at David Geffen School of Medicine at UCLA.
No vaccine is 100% effective. Though so-called "breakthrough" COVID cases are rare, the virus is circulating widely. What's a vaccinated person to do? And ... not do?
The hope was that if people weren't out drinking, they wouldn't be spreading the coronavirus. There were unforeseen benefits to the ban, which ended last month — and negative impacts as well.
Enticed by what young adults had to share about the pandemic, historian Alexandra Zapruder set out to document history through an online gallery called Dispatches from Quarantine.
Drugs that can help keep COVID-19 patients out of the hospital are playing only a small role in Michigan, where the pandemic is accelerating. Logistical challenges are to blame.
The Supreme Court has approved an inquiry into President Jair Bolsonaro's pandemic response. Doctors Without Borders says the country's approach has led to a "near collapse of Brazil's health system."
A majority of white, rural conservatives in Tennessee are open to getting the vaccine at some point, but at least 45% won't consider it. Rates in Alabama, Georgia and Mississippi are also lagging.